This week in the world of finance, The Numbers fund experienced a nuanced journey with mixed outcomes in its equity portfolio. Engaging in strategic plays, the fund went long on shares from two significant sectors, defense and healthcare, through Raytheon Technologies Corporation and Bristol-Myers Squibb Company, both of which painted a contrasting picture in the…

At The Numbers, we prioritize the safety and growth of your investments by employing comprehensive equity risk management strategies. Our meticulous approach to capital allocation ensures that every decision we make is backed by thorough analysis and proven methodologies. Here’s a closer look at how we manage risk to maximize your returns. Informed by Market…

This week, The Numbers portfolio showcased a mixed bag in its equity trades, resulting in an overall balance between gains and losses, maintaining a steady 0.00% net change. Despite this apparent stillness, the portfolio outperformed the S&P 500, which dipped by 1.84%, underscoring a relatively robust strategy amidst market fluctuations. Diving into the specifics, Caterpillar…

The Numbers certainly had an eventful week on the stock market, trading in a diverse portfolio of 6 equities. Let’s break down the action. Taking the helm with Tesla, it was a wild ride as our long position soared by a remarkable 12.42%. The electric vehicle giant clearly revved up its performance, likely driven by…

In a week full of market twists and turns, The Numbers navigated through 2 trades in its portfolio. Let’s dive into the performances of these selected equities. Bullish on Tesla, The Numbers rode the electric vehicle wave, resulting in a dazzling return of 12.42%. As Tesla continues to dominate the EV market with innovative technology…